verona pharma merck - Search News

News

Merck shells out $10 billion for Verona

Merck shells out $10 billion for Verona in bid to diversify beyond Keytruda

Merck said on Wednesday it will acquire UK-based Verona Pharma for about $10 billion, gaining a promising respiratory treatment as it faces pressure to diversify beyond its blockbuster cancer drug Keytruda.

· 4d · on MSN

Merck to Buy Verona Pharma in $10 Billion Deal

· 4d · on MSN

Merck dives into COPD treatments with $10 billion purchase of Verona Pharma

Merck's Verona Acquisition: Plugging A $4B Hole In A $20B Gap

Merck’s recent acquisition announcement sends a strong signal regarding its urgency to tackle the impending Keytruda patent ...

4don MSN

Merck spends $10 billion for Verona, gaining access to its COPD medication

Pharmaceutical giant Merck is buying Verona Pharma, a company that concentrates its efforts on respiratory diseases, in an ...

4hon MSN

Notable healthcare headlines for the week: Trump’s tariff threat, Merck, UnitedHealth and Moderna in focus

Explore last week's key healthcare market trends, top gainers & losers, major deals, Trump's tariff plans, FDA approvals, and significant legal updates.

4don MSN

Merck nears about $10 billion deal for London-based lung therapy firm Verona, FT reports

U.S. drugmaker Merck is nearing a deal worth about $10 billion to buy Verona Pharma, a company focused on therapies for lung ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results